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Abstract 
From the efforts of a number of Canadian institutions and private industry collaborations, direct production of 99mTc using 
medical cyclotrons has recently been advanced from a 1970’s academic exercise to a commercial, economically viable solution 
for regional production.  Using GE PETtrace 880 machines our team has established preliminary saturated yields of 2.7 GBq/μA, 
translating to approximately 174 GBq after a 6 hour irradiation. The team is in the process of assessing the accuracy and 
reliability of this production value with a goal of optimizing yields by up to 50%. 
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1. Introduction 
Technetium-99m (99mTc) continues to be the most widely used radioisotope in nuclear medical imaging today [1], 
with over 30,000 scans performed with this isotope in the United States each day and global consumption exceeding 
40 million scans per year [2]. 99mTc is typically obtained from the in situ decay of 99Mo on a 99Mo/99mTc generator, 
which contains high specific activity 99Mo embedded onto a small alumina column [3]. Daily extraction of 
[99mTc]TcO4− from generators has come to define community expectations of availability and workflow when 
dealing with 99mTc-based radiopharmaceuticals. 
The parent isotope, 99Mo is currently produced in nuclear reactors by the fission and recovery of 99Mo from 235U. 
However, the fragility of 99Mo supply has recently come to light during recent shutdowns at two leading production 
sites [4]. These shutdowns were at times exacerbated by concurrent shutdowns of both the NRU and HFR reactors in 
Canada and the Netherlands. Furthermore, the Canadian NRU reactor, which supplies 35%–40% of the global 
demand of 99Mo, will terminate its isotope production service in 2016 [5]. Other reactors supplying 99Mo are 
typically more than 40 years old and are at risk of prolonged or permanent shutdown in the near future, creating a 
risk for loss of a long-term, stable supply of 99Mo for medical purposes [6].  
By leveraging the existing infrastructure of legacy research reactors, the fission of enriched 235U has long been a 
cost-effective approach to produce large quantities of high-specific-activity 99Mo. However, the cost of building new 
nuclear reactors for isotope production is extremely high and when coupled to a requirement of full cost recovery on 
radioisotope production [7-9], future prices of reactor-sourced 99Mo are estimated to rise dramatically [8]. This price 
increase will be compounded by the effects of a shift from highly enriched uranium (HEU) to low enriched uranium 
(LEU) targets (Global Threat Reduction Initiative[48]) for 99Mo production [7].  
Aside from the adaptation of using LEU (i.e. 235U content <20%) in existing reactors, the recent supply 
disruptions have prompted several governments to fund the development of alternative methods for the production of 
99Mo or the direct production of 99mTc itself. Fission-based alternatives include the Aqueous Homogenous Solution 
Reactor concept [10], and the Target Fuel Isotope Reactor concept [11]. Neutron activation methods include the 
irradiation of enriched 98Mo targets in research [4,12], or power reactors [13]; while accelerator-based production 
methods [14] of both 99Mo and 99mTc include 238U photofission [15,16], phototransmutation of 100Mo via the 
100Mo(J,n)99Mo channel [17,18] or the direct production of 99mTc via the 100Mo(p,2n) transformation [19,20]. 
In 1971, Beaver and Hupf [19] first reported the direct production of 99mTc from both natural and enriched 100Mo 
powder and foil targets. Yields were determined using low level irradiations on stacked Mo foils (13 disks, 0.003 in 
thick, 79 mg/cm2) with 22 MeV protons over 0.0061 μA.hr and substantiated with 97.42% enriched Al-encapsulated 
100Mo powder irradiations at 15.2, 20.2 and 21.4 MeV over 4.6x10-4 to 2.96x10-2 μA.hr. Extrapolating these results, 
the authors suggest a 400 μA, 25 MeV irradiation should produce 14 Ci/hr of 99mTc and 750 mCi/hr of 99Mo. 
However, given the availability of 99Mo, there was little motivation to explore this production option further, and 
much of the work done over the past 4 decades has been limited to several groups [21 - 26] revisiting and refining 
the cross sectional probability of the 100Mo(p,x) transformation. Following the extended outage of the NRU reactor 
the Canadian federal government initiated programs that have led to the development of practical [27] and large-
scale cyclotron production methods [28].  
There are currently over 950 small medical cyclotrons manufactured by several companies (ACSI, GE, IBA, 
Siemens, Sumitomo, Best, etc.) installed around the world. Approximately 550 of these machines operate above 16 
MeV and are capable of producing appreciable quantities of 99mTc. The distribution of these cyclotrons by 
manufacturers is shown in Figure 1.  
GE is presently the market leader in small medical PET cyclotrons with an installed base of more than 320 
cyclotrons worldwide as seen in Figure 2. GE offers the PETtrace 800 (Figure 3) and MINItrace (PETtrace 700) 
series of machines, with a new, smaller unit under development, the PETtrace 600. About 250 of these installed 
machines are PETtrace 800 series cyclotrons operating at 16.5 MeV protons. Here we report our results in 
implementing a complete solution for the direct production of 99mTc on the GE PETtrace cyclotron. For the purpose 
of the present work, we will discuss technology developed only for those machines with final proton energy t16 
MeV. For the PETtrace 800 series, the maximum accelerated beam intensity is 130 μA. 
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Figure 1 - Estimated PET cyclotron numbers by manufacturers (with data from ACSI, GE, IBA and Siemens, Sumitomo data estimated). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 - GE PETtrace 800 series cyclotrons worldwide distribution. Approximately 250 installed machines. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 - GE PETtrace 800 cyclotron. 
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2. Experimental 
2.1. Cyclotron System – PETtrace 880 
All irradiations were performed using either a self-shielded (Lawson Health Research Institute, London, ON) or a 
vaulted (Centre for Probe Development and Commercialization, Hamilton, ON) GE PETtrace cyclotron, both of 
which had been upgraded to enable 130 μA beam current onto a single target. Each machine has 6 beam ports, 
capable of simultaneous irradiation (with a sum total of 130 μA) to 2 target stations. A self-shielded machine 
maintains a configuration of shielding units that can be moved to enable access to the cyclotron system itself. A 
vaulted machine maintains an identical core cyclotron configuration including target stations and services but is 
housed and shielded in a concrete vault. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 - 100Mo target assembly as installed on beam port 2 of a GE PETtrace cyclotron. Services panel is shown to the left of the cyclotron 
beam ports. 
2.2. Target System Design 
A combination of the proximity of the target services panel (see Figure 4), the convoluted transfer path and the 
limited target cave capacity in the self-shielded machine mandated a solid target system that minimized the size of 
all components [29]. A target of minimum length was designed with an aluminum target holder, capable of 
accommodating a 28 mm diameter target plate which had mounted to it a 17 mm diameter enriched 100Mo disk 
brazed to the backing as described elsewhere (Figure 5, [30]).  
 
 
 
 
 
 
 
 
 
 
 
Figure 5 - Pressed-Sintered and Brazed Mo-Cu Target Disc for GE PETtrace Cyclotron. 
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Prior to irradiation, the capsule and target disk were assembled manually and placed in a holder designed into the 
mechanical target transfer drive [31]. The capsule was then delivered through the transfer line to the target station at 
the cyclotron. After irradiation, the targets were retracted with the same tape drive to the hotcell for dissolution and 
purification. 
2.3. Target Disk Preparation 
As we report elsewhere [30], enriched 100Mo targets were prepared following conventional press & sinter 
methodology. 100Mo powder was obtained commercially from Isoflex (San Francisco, USA) in various enrichments. 
A green pellet was produced by compacting approximately 1.5 g of this powder using a cylindrical tool of 20 mm 
diameter and hydraulic press (Across International, Livingston, USA). A pressure between 25 kN/cm2 and 250 
kN/cm2 was applied for 0.5 min after which the green pellet was sintered in a reducing atmosphere (Ar/2% H2) at 
1,700oC for five hours. The resulting 100Mo plates have 90-95% of the bulk density of molybdenum. The 100Mo plate 
was then furnace brazed at 750oC onto a backing manufactured from a dispersion strengthened copper composite 
(e.g., Glidcop AL-15) using a high temperature silver-copper brazing filler (Johnson Matthey, Royston UK). This 
process yields a unique, mechanically and thermally robust target system for high beam power irradiation. 
2.4. Target Irradiations  
Targets were irradiated at 100 μA for 15 minutes and 130 μA for 30 minutes and visually inspected after each 
irradiation. Subsequent irradiations were performed at 130 μA for 2 hours and 6 hours. Beam current was brought 
up over a few minutes. In all cases irradiations proceeded uneventfully with no vacuum changes or cyclotron 
instabilities. 
2.5. Target Dissolution and Purification Process 
99mTc was isolated from irradiated targets, while mounted in the target capsule, by placing the capsule on a 
custom aluminum dissolution chamber in a hot cell (Comecer). Co-dissolution of the 100Mo/99mTc mixture was 
accomplished using 40 mL of 30% H2O2 pumped through the dissolution chamber at ~1 ml/min while the chamber 
was heated to ~95oC. The dissolved target solution was then transferred to a vessel containing 8 g of NaOH in 10 
mL of distilled, deionized H2O and thoroughly mixed prior to transfer to the automated purification module (Trasis 
MiniAiO, Ans, Belgium). Na99mTcO4 was isolated using a solid-phase extraction procedure previously published by 
our group [28,32]. Briefly, a 4 M NaOH solution  containing 99mTcO4 and 100MoO4 was transferred at a rate of 2 
mL/min through a cartridge containing 500 mg of Chemmatrix resin (PCAS Biomatrix, PQ, Canada). The  Tc was 
immobilized on the resin while 100Mo and other non-Tc radionuclidic impurities were diverted to a waste-recovery 
vessel for future recycling. After loading, the resin was washed using 10 mL of 4 M NaOH which was added to the 
same waste-recovery vessel. The resin was readily eluted with water (2 mL/min) through a Dionex On-Guard II H 
cartridge (Sunnyvale, USA) and onto a second-stage basic alumina (Waters) column. A purification efficiency of 78 
± 8 % (n=3) was determined by comparing the radioactivity in the product vial to the inventory of radioactivity in 
the waste vials and remaining on the cartridges and filters. 
3. Results and Discussion 
The GE PETtrace cyclotron represents the largest installed cyclotron base in the world today (Figure 1). With an 
on-target proton energy of ~16.5 MeV, we hypothesized that this machine could produce an appreciable quantity of 
99mTc with the proper configuration. One critical requirement is the development of high current (130 μA) solid 
target hardware, also capable of withstanding high power density (< 1.2 kW/cm2 average) over an extended period 
of time. Our team has overcome several challenges en route to establishing a simple, reliable production route for 
Ci-quantity production of 99mTc. Such an approach amounts to decentralized production in which any number of 
cyclotron centers would work together to provide 99mTc as part of a network of distribution sites. This model has 
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precedence in how 18F is produced and distributed to various PET centers today. Such as paradigm could form an 
appreciable component of the future 99mTc isotope production landscape, especially in light of the upcoming 
cessation of 99Mo production at the Chalk River reactor in 2016 [15]. 
3.1. Target plate preparation 
One of our key challenges was to develop a high power density target, capable of withstanding multi-hour, high 
current irradiations at the kW power level. Mo metal has a high melting temperature (>2600oC), but without 
adequate heat transfer and cooling, this temperature could easily be achieved during irradiation, potentiating 
premature activity mobilization, or worse, catastrophic target failure. In addition, such a high melting temperature, 
when coupled to the reactivity with oxygen at relatively low temperatures (~440oC), lead to a formidable challenge 
in target manufacture. We explored electroplating [33] and sugar-composite [34], and more recently electrophoretic 
deposition (EPD) [28], while others have looked at thermocompression bonding to aluminum [35]. Our past success 
with EPD enabled 240 μA irradiations at 18 MeV albeit with an average power density of 0.3 kW/cm2, achieved by 
having the target oriented at 10o relative to the incident beam. When we attempted EPD deposited targets for the GE 
PETtrace, we discovered that despite the lower power (16.5 MeV, 130 μA), the orthogonal orientation and higher 
power density caused the thicker, porous Mo layer to fail, as was evident within minutes of irradiation at beam 
currents as low as 40-60 μA (Figure 6). To mitigate this issue, we developed the novel pressed, sintered, and brazed 
(PSB) target system reported here. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 - Targets manufactured using EPD (left) and PSB (right) methods. The target on the left was irradiated for less than 1 hour at 60 μA 
while the target on the right at maximum current (130 μA). 
 
3.2. Target irradiations 
Up to 4.7 Ci of 99mTc have been produced on the GE PETtrace to date. The saturated production yield (2.7 
GBq/μA), was consistent with calculated yields at 16.5 MeV and remained constant between 2 hour and 6 hour 
irradiations [24,36]. 
3.3. Target dissolution 
The dissolution rate of the molybdenum is controlled by the flow rate of peroxide over the face of the plate and 
by the temperature of the apparatus. By minimizing the volume of the apparatus the volume of peroxide in contact 
with the molybdenum is also minimized thus preventing the exothermic reaction from getting out of control. In our 
initial tests we recirculated the peroxide but found this process to be unstable as the molybdenum content in the 
peroxide reservoir occasionally caused the reservoir to overheat and expel material. In addition the peroxide 
concentration declined as the process continued so the dissolution rate of the molybdenum declined during the 
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process. Withdrawing fresh peroxide from one reservoir and depositing the effluent of the dissolution chamber in a 
second reservoir resolved both of these issues.   
The mass of molybdenum on the target plate is sufficient to stop the entire proton beam before it enters the 
copper backing in order to prevent the co-production of zinc isotopes. As such the complete dissolution of the 
molybdenum is not necessary to recover the entire Tc radioactivity. We have found that it is advantageous to halt the 
dissolution process when approximately 25 mL of peroxide have been pumped through the dissolution chamber as 
this is sufficient to extract the Tc but minimizes the amount of copper that is dissolved from the target plate. We 
presently measure 1.06 ± 0.12 g (N=4) of material dissolved from the target plate. Excessive copper was seen to 
plug filters specifically added to the apparatus to prevent the copper from possibly plugging the downstream 
cartridges of the purification apparatus. Experiments with modifying the dissolution process to minimize the co-
dissolution of the copper are currently underway and appear promising. A later processing step will likely be 
implemented to recover the remaining 100Mo for recycling. 
3.4. Pertechnetate purification 
The 99Mo/99mTc generator contains high specific activity 99Mo embedded onto an alumina column [3]. Daily 
extraction of [99mTc]TcO4 is accomplished in a hospital and/or radiopharmacy setting by exploiting the mobility 
differences between the 99MoO42− and 99mTcO4− ions on alumina in isotonic saline. Selective chromatography 
defines the radionuclide generator concept and also largely defines the expectations of the nuclear medicine 
community when dealing with 99mTc-based radiopharmaceuticals. For this reason, we sought to tailor any alternative 
production and purification method of 99mTc to US Pharmacopeia (USP) standards for chemical, radiochemical and 
radionuclidic purity. But we also wanted enable access to 99mTc without requiring substantial infrastructure changes 
within the healthcare community. Alternative 99mTc purification methods have recently been reviewed [37].  
We have tested several methods applicable to recovering 99mTc from a bulk level of Mo, most of which exploit 
the favorable free energy of hydration of TcO4− over other components of the target mixture [38]. Various resins are 
commercially available, including ABEC-2000, AnaLig and more recently, Chemmatrix resins [39]. Using an 
automated column purification method, we were able to establish a high-efficiency, reliable separation with 
Chemmatrix as the first stage and an in-line SCX-basic alumina SepPak series as the second stage. 
The entire pertechnetate purification process is readily amenable to meet good manufacturing practice (GMP) 
compliant production. This purification process is applicable for separation of Ci-quantities of sodium pertechnetate 
(Na[99mTcO4]) from any solution containing excess molybdate (MoO42-) ions. 
3.5. Radionuclidic purity analysis 
Cyclotron production of 99mTc will result in the concomitant production of minor Tc radioimpurities depending 
on the isotopic composition of the target material, proton beam energy and irradiation time [36]. Preliminary gamma 
spectroscopy experiments suggest that the technetium radionuclide content at end of bombardment is over 99.5% 
relative to all other technetium radioisotopes produced. In recognizing the importance of technetium impurities to 
Na99mTcO4 shelf-life and downstream kit formulation as well as patient dose, a thorough, quantitative radionuclidic 
analysis is currently underway and will be reported under separate cover. 
4. Planned efforts to increase beam intensity 
The negative ions are generated in two internal cold cathode PIG type ion sources, as shown in Figure 7, and are 
accelerated to the final energy by RF high voltage. Extraction is performed using carbon stripper foils. As we saw in 
the previous section, to produce efficiently 99mTc directly by proton bombardment of solid 100Mo metal target, we 
would need high intensity beams, preferably in the 16-19 MeV range. In order to increase the beam intensity, we 
would need more ions extracted from the ion source. This would require higher gas flow to the ion source. Because 
the ion sources are sitting in the center of the cyclotron vacuum tank, the gas introduced in the ion source will flood 
the vacuum tank and contribute to the collisional stripping of the negative ions. The extra electron on the H- ion is 
bound only with 0.75 eV and it is easily lost in collisions with residual gas along the accelerating path. As soon as 
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an electron is stripped in a collision, that particle becomes a neutral atom and the magnetic and electric fields will 
not act on it, effectively losing it to the vacuum vessel walls. This puts a limit in increasing the gas flow to the ion 
source; there is an optimum gas flow to maximize the accelerated beam intensity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7 - Present dual PIG ion source of PETtrace 800 cyclotron for H- and D-. 
 
One way to increase the accelerated beam intensity with an internal PIG ion source is to increase the usage 
efficiency of the ions extracted from the ion source. Our simulation studies [44] done for benchmarking the existing 
design in preparation for a more radical change described in the next section, showed that the present Central 
Region is far from being fully optimized. There is considerable loss on different CR components during the first 
accelerating turn. We anticipate that by giving up the dual beam capability and replacing the present larger twin PIG 
source with a H- only source, similar to the one used in the MINItrace cyclotrons, as seen in Figure 8, will allow 
more room for the first turn, which – together with some other component redesign – will decrease greatly the first 
turn losses. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8 - MINItrace H- PIG ion source. 
 
The other method to use the available ions from the PIG source more efficiently is to improve the ion extraction. 
Presently the extraction is done with an electrode which is at the variable dee electrode potential. This means that 
the sinusoidal changing extraction voltage [-38 kV to +38 kV] will extract H- ions only half or the period, the 
negative voltages will extract protons from the plasma of the ion source. These protons are bent in the opposite 
direction and will not get accelerated by the dee electrodes. In the space charge limit, the extracted ion beam 
intensity is proportional with the extraction voltage at 3/2 power (Child-Langmuir law). Our simulations showed 
that only ions extracted ~+/-20 degrees around the maximum RF voltage value will make all the way to the 
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extraction, as seen in Figure 9. If we can somehow enlarge this angular acceptance window, we can accelerate more 
ions extracted from the same plasma, in this way we can increase the accelerated beam intensity without increasing 
the gas fed in the PIG source. Alternatively, it would be possible to reduce the gas flow in the ion source and with 
more efficient use of the available extracted ions, still maintain the same final accelerated intensity at a lower 
background pressure. This would decrease the collisional stripping and the resulting activation of the cyclotron 
vacuum vessel. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9 - Present and improved RF capture domain. 
 
Hudson et al. [40] invented an extraction system for the Oak Ridge National Laboratory ORIC cyclotron which 
accomplished exactly this goal. They placed an electrode biased at a DC high voltage (typically around 20 kV) 
between the PIG source exit slit and the RF puller electrode as seen in Figure 10. An added benefit of the DC biased 
intermediate electrode would be the creation of a potential hill for the extracted protons in the negative half of the 
RF voltage. In this way the back acceleration and bombardment of the exit slit of the PIG source chimney would be 
greatly diminished, contributing to the extension of the lifetime of the ion source. 
 
 
 
 
 
 
 
 
 
 
 
Figure 10 - Internal PIG ion source with DC biased puller electrode [Error! Bookmark not defined.]. 
Besides the stripper foil wear, the ion source wear is the most common failure of an H- cyclotron, which of 
course, can be prevented with well scheduled maintenance. However, increasing the period between maintenance 
shutdowns would be an important improvement for most of the PET cyclotron operators, reducing also the dose 
received by the service personnel. Engineering an extra electrode biased to +20 kV is not a trivial task; it will 
require detailed simulation work and possible redesign of the whole Central Region (CR). By eliminating the D- ion 
source and associated deuterium gas line, it will be possible to use the freed gas feedthrough place on the cyclotron 
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vacuum tank to use a HV feedthrough instead and bring in high voltage in a place where there is very little room for 
any added hardware.  
It is anticipated that it may be feasible to make these hardware modifications on cyclotrons already in service. 
This will allow the current GE cyclotron operators to increase their cyclotron output intensity to ~200 – 250 μA.  
We believe that this relatively small modification of the CR of the existing installed base cyclotrons will be a very 
attractive avenue for most of our users. 
A much more radical approach is to remove the ion source from the cyclotron and to use an external H- source 
with an associated Low Energy Beam Transport line and a spiral inflector. Such configurations are already offered 
by some of the commercial manufacturers, e.g., the TR19 and TR24 cyclotrons made by ACSI [41]. The external 
ion source is more common on larger cyclotrons, as the TR30 by ACSI, or Cyclone 70 by IBA [42] etc. which are 
used primarily for SPECT isotope production. The vast majority of the cyclotrons used for research are also 
equipped with external ion sources. Presently, the only PET cyclotrons in regular service equipped with external ion 
sources are made by ACSI and they are rated 300 μA [41]. Best Cyclotrons are advertising a 14 MeV PET cyclotron 
equipped with external ion source capable accelerating 400 μA [43], but to the authors’ best knowledge, there are no 
such cyclotrons yet in service.  
Our preliminary feasibility study based on charged particle trajectory simulations with the SNOP code developed 
in the Joint Institute for Nuclear Research, Dubna showed that it is possible to accelerate ~500 μA H- beam in a 
modified version of the PETtrace 800 cyclotron using an external H- ion source capable delivering 10 mA H- beam 
at ~25-30 kV extraction voltage. The conceptual layout of this cyclotron is shown in Figure 11. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11 - Conceptual layout of the PETtrace 800 cyclotron equipped with an external H- ion source. 
There are several types of external H- ion sources examined for our purpose. The most mature design is the 
filament based volume cusp H- ion source developed in TRIUMF many years ago by Kuo et al. [44]. This type of H- 
ion source or some version of it is in use on the ACSI, IBA or Best Cyclotrons made machines, as well as the 
cyclotrons designed in CIAE in Beijing, China [45]. This ion source is commercially available from a Canadian 
accelerator company D-Pace [46]. GE has conceptualized a filament based ion source, shown in Figure 12. The only 
drawback of this type of ion source is the limited lifetime of the filament (300 to 500 hours, depending on the ion 
source output). The Low Energy Beam Transport line (LEBT) being equipped with a gate valve between the ion 
source and the rest of the system, it is relatively straightforward operation to replace the filament, without venting 
the whole LEBT and cyclotron. The downtime associated with the filament replacement is estimated only to couple 
of hours needed to physically replace the back plate of the ion source with the fresh filament and to pump down the 
ion source volume. 
Another attractive solution would be a microwave H- ion source, as described by Jayamanna et al. [47]. The 
source has been tested for H- and achieved 2.1 mA at 0.25π mm mrad normalized emittance for 500 W of input 
power at a frequency of 2.45 GHz. The main advantage of this type of ion source is the lack of any consumable part, 
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which theoretically makes this ion source infinite lifetime. With some further development work it seems reasonable 
to attain 5-10 mA intensity from such type of ion source, more than enough for a small medical cyclotron to 
accelerate ~500 μA beam. 
 
 
 
 
 
 
 
 
 
 
Figure 12 - Conceptual design of the GE filament based H- ion source and extraction electrode system. 
5. Conclusions 
We have engineered and demonstrated the production of large quantities of 99mTc on GE PETtrace cyclotrons. 
These results demonstrate the feasibility of supplying a medium to large population base from a single cyclotron and 
that a network of such machines could provide a decentralized and redundant supply of Na[99mTcO4]. With some 
modifications of existing cyclotron infrastructure, this approach could be used to implement a highly decentralized 
medical isotope production model, eliminating the requirement for enriched uranium and radioactive waste 
associated with nuclear fission. 
With improvements to the existing ion source, RF capture, etc. we anticipate yields of 7.3-9.1 Ci (270-337 GBq) 
per 6 hr run at 200-250 μA.  By redesigning the PETtrace platform to support an external ion source and thus 
increasing current output to 500 μA, we anticipate single-run production quantities of up to 675 GBq (18.2 Ci) of 
99mTc can be produced in 6 h. These yields would surpass production on a TR19 operated at 300 μA at 18 MeV [28]. 
Our target dissolution and 99mTc purification process was completed in approximately 75 min with average 
purification yields of 84%. Further optimization is possible to reduce the processing time and improve yields. 
Upgrading the intensity of the PETtrace cyclotrons, a large installed base will be capable to produce directly 
99mTc, as well as a new cyclotron with external ion source will be the first choice for an ultimate intensity PET 
cyclotron, capable also to produce ~20 Ci 99mTc in a 6 hours run with a 500 μA beam intensity. Increasing the 18F 
production capability is also a strong motivator for many of our present and future customers, anticipating an 
increased demand for an ever increasing variety of different molecular imaging agents labelled with 18F. Even at the 
present demand, reducing the necessary irradiation time with available increased intensity can change several 
operating business models, to the benefit of the customer and ultimately making the PET imaging modality more 
accessible to a larger segment of the population. 
Personal Note 
During the publication of this journal proceeding, Peter Zavodszky unexpectedly passed away.  We are all saddened 
by the loss of such a talented physicist and very good friend. Peter will be missed  
Acknowledgements 
The authors would also like to thank Natural Resources Canada (NRCan), the Canadian Foundation for 
Innovation (CFI), Canadian Institutes for Health Research (CIHR) and the Natural Sciences and Engineering 
Research Council (NSERC) for funding. Resources were also provided by St. Joseph’s Healthcare (London, ON), 
the BC Cancer Research Foundation, TRIUMF and McMaster University. 
394   P. Schaffer et al. /  Physics Procedia  66 ( 2015 )  383 – 395 
One of the authors (PAZ) would like to thank R. Watt (ACSI), J.-M. Geets (IBA) and J. Hinderer (Siemens) for 
providing data about their installed base PET cyclotrons. 
References 
[1] Eckelman WC. Unparalleled contribution of technetium-99m to medicine over 5 decades. JACC-Cardiovasc Imag 2009;2:364–8. 
[2] Einstein AJ. Breaking America’s dependence on imported molybdenum. JACC Cardiovasc Imag 2009;2:369–71. 
[3] Boyd RE. Technetium generators — status and prospects. Radiochim Acta 1987;41:59–63. 
[4] Pillai MR, Dash A, Knapp FF Jr. Sustained availability of 99mTc: possible paths forward. J Nucl Med 2013;54:313–23. 
[5] Expert Review Panel on Medical Isotope Production. 2009. http://www.nrcan.gc.ca/sites/www.nrcan.gc.ca/files/ 
energy/pdf/eneene/sources/uranuc/pdf/panrep-rapexp-eng.pdf. 
[6] Van Noorden R. The Medical Testing Crisis. Nature 2013;504:202-4. 
[7] OECD-NEA (2012) No. 7129, The Supply of Medical Radioisotopes: Market Impacts of Converting to Low-Enriched Uranium Targets for 
Medical Isotope Production, OECD, Paris, France, ISBN 978-92-64-99197-2.  
[8] OECD-NEA (2011) No. 6985, The Supply of Medical Radioisotopes: the Path to Reliability, OECD, Paris, France, ISBN 978-92-64-99164-4. 
[9] OECD-NEA (2010) No. 6967, The Supply of Medical Radioisotopes: An Economic Study of the Molybdenun-99 Supply Chain, OECD, Paris, 
France, ISBN 978-92-64-99149-1. 
[10] International Atomic Energy Agency. Homogeneous Aqueous Solution Nuclear Reactors for the Production of Mo-99 and Other Short Lived 
Radioisotopes. IAEA TECDOC Report 1601. 
[11] Parma et al. Sandia National Laboratories Medical Isotope Reactor Concept. Report SAND 2010-1816. Albuquerque, NM: SAND; 2010 
[12] Ryabchikov AI, Skuridin VS, Nesterov EV, Chibisov EV, Golovkov VM. Obtaining molybdenum-99 in the IRT-T research reactor using 
resonance neutrons. Nucl Instrum Methods Phys Res. Sect B. 2004;213:364–8. 
[13] Press release, GE-Hitachi, 25 January 2010. Available at: www.ge-energy.com/about/press/en/2010_press/ 012510.htm 
[14] Lambrecht RM, Sekine T, Vera Ruiz H. Alice predictions on the accelerator production of molybdenum-99. Appl Radiat Isot 1999;51:177–
182. 
[15] Ruth T. Accelerating production of medical isotopes. Nature 2009;457:536–537. 
[16] Fong A, Meyer TI, Zala K. Making Medical Isotopes, Report of the Task Force on Alternatives for Medical isotope Production. Vancouver, 
Canada: TRIUMF; 2008 
[17] Ross C, et al. Using the Mo-100 photoneutron reaction to meet Canada's requirement for Tc-99m. Phys. Can. 2010;66:19-24. 
[18] Galea R, Ross C, Wells RG, Reduce, reuse and recycle: A green solution to Canada's medical isotope shortage. Appl Radiat Isot 
2014;87:148-51. 
[19] Beaver and Hupf, Production of 99mTc on a Medical Cyclotron: A Feasibility Study. J Nucl Med 1971;12:739–41 
[20] Lagunas-Solar MC, Kiefer PM, Carvacho OF, Lagunas CA, Cha YP. Cyclotron production of nca Tc-99m and Mo-99 — an alternative non-
reactor supply source of instant Tc-99m and Mo-99/Tc-99m generators. Appl Radiat Isot 1991;42:643–57. 
[21] Lagunas-Solar MC, Kiefer PM, Carvacho OF, Lagunas CA, Cha YP. Cyclotron production of NCA 99mTc and 99Mo. An alternative non-
reactor supply source of instant 99mTc and 99Mo - 99mTc generators. Int J Rad Appl Instrum A 1991;42:643-57. 
[22] Scholten B, Lambrecht RM, Cogneau M, Vera Ruiz H, Qaim SM. Excitation functions for the cyclotron production of Tc-99m and Mo-99. 
Appl Radiat Isot 1999;51:69–80. 
[23] Takács S, Szűcs Z, Tárkányi F, Hermanne A, Sonck M. Evaluation of proton induced reactions on Mo-100: new cross sections for 
production of Tc-99m and Mo-99. J Radioanal Nucl Chem 2003;257:195–201. 
[24] Gagnon K, Benard F, Kovacs M, et al. Cyclotron production of 99mTc: experimental measurement of the 100Mo(p,x)99Mo, 99mTc and 99gTc 
excitation functions from 8 to 18 MeV. Nucl Med Biol. 2011;38:907–16. 
[25] Lebeda O, Pruszyński M. New measurement of excitation functions for (p,x) reactions on natMo with special regard to the formation of 
95mTc, 96m+gTc, 99mTc and 99Mo. Appl Radiat Isot 2010;68:2355–65. 
[26] Khandaker M, Uddin M, Kim K, Lee Y, Kim G. Measurement of cross-sections for the (p,xn) reactions in natural molybdenum. Nucl Instr 
Meth Phys Res B 2007;262:171–81. 
[27] Guerin B, Tremblay S, Rodrigue S, Rousseau JA, Dumulon-Perreault V, Lecomte R, et al. Cyclotron production of Tc-99m: an approach to 
the medical isotope crisis. J Nucl Med 2010;51:13N–6N. 
[28] Bénard F, Buckley KR, Ruth TJ, Zeisler SK, Klug J, Hanemaayer V, Vuckovic M, Hou X, Celler A, Appiah JP, Valliant J, Kovacs MS, 
Schaffer P. Implementation of Multi-Curie Production of 99mTc by Conventional Medical Cyclotrons. J Nucl Med 2014;55:1017-22 
[29] Buckley KR, Cyclotron Production of Tc-99m, Cyclotrons2013 Conf Proc, 2014;Mar:482-6. 
[30] Zeisler SK, Hanemaayer V, Buckley KR, Hook BK, McDiarmid S, Corsaut J, Kovacs M, Cockburn N, Economou C, Harper R, Ruth TJ, 
Schaffer P. High Power Targets for Cyclotron Production of 99mTc. AIP Conf Proc 2014 (WTTC15); in press (2014). 
[31 Klug J, Buckley KR, Zeisler SK, Dodd, M, Tsao P, Hoehr C, Economou C, Corsaut J, Appiah JP, Kovacs MS, Valliant JF, Benard F, Ruth 
TJ, Schaffer P. A new transfer system for solid targets. AIP Conf Proc 2012 (WTTC14);1509:146-51. 
[32] Morley TJ, Dodd M, Gagnon K, Hanemaayer V, Wilson J, McQuarrie SA, English W, Ruth TJ, Bénard F, Schaffer P. An Automated 
Module for the Separation and Purification of Cyclotron-Produced 99mTcO4-. Nuc Med Biol 2012;39:551-59. 
[33] Morley TJ, Penner L, Schaffer P, Bénard F, Ruth TJ, Asselin E. The deposition of smooth metallic molybdenum from aqueous electrolytes 
containing molybdate ions. Electrochem Commun 2012;15:78–80. 
[34] Dmitriev S, Buklanov G, Starodub G, Shishkina T, Shishkin S. Production of high purity Tc-97 for environmental research. Czech J Phys. 
1999;49:823–24. 
[35] Gagnon K, Wilson JS, Holt CMB, Abrams DN, McEwan AJB, Mitlin D, McQuarrie SA. Cyclotron Production of 99mTc: Recycling of 
enriched 100Mo metal targets. Appl Radiat Isot 2012;70:1685-90. 
[36] Celler A, Hou X, Benard F, Ruth T. Theoretical modeling of yields for protoninduced reactions on natural and enriched molybdenum 
targets. Phys Med Biol 2011;56:5469–84. 
 P. Schaffer et al. /  Physics Procedia  66 ( 2015 )  383 – 395 395
[37] Dash A, Knapp FF Jr, Pillai MR. 99Mo/99mTc separation: an assessment of technology options. Nucl Med Biol 2013;40:167–76. 
[38] Huddleston JG, Griffin ST, Zhang J, Willauer D, Rogers RD. Metal Ion Separations in Aqueous Biphasic Systems and with ABECTM Resins. 
Methods Biotechnol 2000;11:77-94. 
[39] Bénard F, Zeisler S, Vuckovic M, Lin K-S, Zhang Z, Colpo N, Ruth TJ, Schaffer P. Cross-linked polyethylene glycol beads to separate 
99mTc-pertechnetate from low specific activity molybdenum. J Nucl Med 2014; accepted, in press.   
[40] Hudson ED, Lord RS Mallory ML, Cyclotron internal ion source with DC extraction, US patent 3,867,705 (Feb.18, 1975). 
[41] http://www.advancedcyclotron.com/ 
[42] http://www.iba-radiopharmasolutions.com/products/cyclotrons 
[43] http://www.bestcyclotron.com/ 
[44] Kuo T, Yuan D, Jayamanna K, McDonald M, Baartman R, Schmor P, Dutto G. On the development of a 15 mA direct current H multicusp 
source. Rev Sci Instr 1996;67:1314-16. 
[45] Zhang T, Yin Z, Zhong J, Cui T, Li M, Wei S, Song G, Wu L, Ji B, Xing J, Qin J, Jia X, Hu W, Yang J, An S, Guan F, Zhen X, Wen L, Lin 
J, Li Z, Zhang X, Cai Y, Yang F. Overall design of CYCIAE-14, a 14 MeV PET cyclotron.  Nucl Instr Meth B 2011;269:2950–54. 
[46] http://www.d-pace.com/ 
[47] Jayamanna K, Yuan D, Kuo T, McDonald M, Schmor PW, Dutto G. Microwave-Driven Multipurpose Ion Source. Rev Sci Instrum 1996; 
67:1061-3. 
[48] http://nnsa.energy.gov/aboutus/ourprograms/dnn/gtri 
 
